Excessive antiseptic use: Is there any potential link with microbiome disturbance and possible antimicrobial resistance
DOI:
https://doi.org/10.61561/ssbgjms.v6i04.137Keywords:
Antiseptic Use, Microbiome, Antimicrobial Resistance, InfectionAbstract
Antiseptics have been important in the fight against infectious illnesses, particularly during the COVID-19 pandemic, when antiseptic use skyrocketed globally. Although they are still essential for preventing infections, antiseptics' overuse and carelessness might initiate issues with microbiome disruption. Several recent investigations indicate that excessive use of antiseptics affects the delicate balance of the gut, mouth, and skin microbiota and may potentially cause cross-resistance of pathogenic bacteria. Presently, there is not enough clear clinical evidence to support this claim. The necessity of balanced hygiene practices is underscored in this article. This article discusses possible consequences of antiseptic overuse associated with microbiome disturbance, the mechanism of resistance, public health implications, and information gaps.
References
1. Donaghy JA, Jagadeesan B, Goodburn K, Grunwald L, Jensen ON, Jespers AD, Kanagachandran K, Lafforgue H, Seefelder W, Quentin MC. Relationship of Sanitizers, Disinfectants, and Cleaning Agents with Antimicrobial Resistance. J Food Prot. 2019 May;82(5):889-902. DOI: https://doi.org/10.4315/0362-028X.JFP-18-373
2. Kumar, A., and D. Pal. Antibiotic resistance and wastewater: correlation, impact and critical human health challenges. J. Environ. Chem. Eng. 2018; 6:52–58. DOI: https://doi.org/10.1016/j.jece.2017.11.059
3. Al-Sayah MH. Chemical disinfectants of COVID-19: an overview. J Water Health. 2020 Oct;18(5):843-848. DOI: https://doi.org/10.2166/wh.2020.108
4. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. DOI: https://doi.org/10.1056/NEJMc2004973
5. Safer Cleaning, Sanitizing and Disinfecting Strategies to Reduce and Prevent COVID-19 Transmission. Available at: https://oshce.uw.edu//sites/default/files/documents/FactSheet_Cleaning_Final_UWDEOHS_0.pdf
6. Dindarloo K, Aghamolaei T, Ghanbarnejad A, Turki H, Hoseinvandtabar S, Pasalari H, Ghaffari HR. Pattern of disinfectants use and their adverse effects on the consumers after COVID-19 outbreak. J Environ Health Sci Eng. 2020 Sep 30;18(2):1301-1310. DOI: https://doi.org/10.1007/s40201-020-00548-y
7. Yasseen Iii A, Weiss D, Remer S, Dobbin N, MacNeill M, Bogeljic B, Leong D, Wan V, Mosher L, Bélair G, Thompson M, Button B, Hardy J, Perwaiz S, Smith A, Wootton R. Increases in exposure calls related to selected cleaners and disinfectants at the onset of the COVID-19 pandemic: data from Canadian poison centres. Health Promot Chronic Dis Prev Can. 2021 Jan;41(1):25-29. DOI: https://doi.org/10.24095/hpcdp.41.1.03
8. Tsuzuki S, Koizumi R, Asai Y, Ohmagari N. Trends in antimicrobial consumption: long-term impact of the COVID-19 pandemic. Clin Microbiol Infect. 2025 Apr;31(4):594-599. DOI: https://doi.org/10.1016/j.cmi.2024.12.005
9. Pidot SJ, Gao W, Buultjens AH, Monk IR, Guerillot R, Carter GP, Lee JYH, Lam MMC, Grayson ML, Ballard SA, Mahony AA, Grabsch EA, Kotsanas D, Korman TM, Coombs GW, Robinson JO, Gonçalves da Silva A, Seemann T, Howden BP, Johnson PDR, Stinear TP. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols. Sci Transl Med. 2018 Aug 1;10(452):eaar6115. DOI: https://doi.org/10.1126/scitranslmed.aar6115
10. Xu W-B, Wang Y-F, Meng S-Y, Zhang X-T, Wang Y-R, Liu Z-Y. Effects of antibiotic and disinfectant exposure on the mouse gut microbiome and immune function. Microbiol Spectr. 2024 Nov 5;12(11):e0061124. DOI: https://doi.org/10.1128/spectrum.00611-24
11. Angjelova A, Jovanova E, Polizzi A, Leonardi R, Isola G. Effects of Antiseptic Formulations on Oral Microbiota and Related Systemic Diseases: A Scoping Review. Antibiotics (Basel). 2025 Aug 8;14(8):815. DOI: https://doi.org/10.3390/antibiotics14080815
12. Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016 Apr 13;8(1):39. DOI: https://doi.org/10.1186/s13073-016-0294-z
13. Himabindu CS, Tanish BT, Kumari NP, Nayab SN. Hand sanitizers: Is over usage harmful? World J. Curr. Med. Pharm. Res. 2020; 2: 296–300. URL: https://wjcmpr.org/index.php/journal/article/view/157/115
14. De Gottardi A, McCoy KD. Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease. J. Hepatol. 2011; 55: 1181–1183. DOI: https://doi.org/10.1016/j.jhep.2011.02.035
15. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001 Feb 2;291(5505):881-4. DOI: https://doi.org/10.1126/science.291.5505.881
16. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2):e31951. DOI: https://doi.org/10.1371/journal.pone.0031951
17. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 2011 Dec;48(4):257-273. DOI: https://doi.org/10.1007/s00592-011-0333-6
18. Jahani-Sherafat S, Azimirad M, Alebouyeh M, Ahmadi Amoli H, Hosseini P, Ghasemian-Safaei H, Moghim S. The rate and importance of Clostridium difficile in colorectal cancer patients. Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):358-363. PMID: 31749925.
19. WHO. Antimicrobial resistance, November, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance#:~:text=Antimicrobial%20Resistance%20(AMR)%20occurs%20when,organ%20transplantation%20and%20other%20surgeries
20. Shepherd MJ, Moore G, Wand ME, Sutton JM, Bock LJ. Pseudomonas aeruginosa adapts to octenidine in the laboratory and a simulated clinical setting, leading to increased tolerance to chlorhexidine and other biocides. J Hosp Infect. 2018 Nov;100(3):e23-e29. DOI: https://doi.org/10.1016/j.jhin.2018.03.037
21. Ferraz MP. Antimicrobial Resistance: The Impact from and on Society According to One Health Approach. Societies. 2024; 14(9):187. DOI: https://doi.org/10.3390/soc14090187
22. Sharma S, Chauhan A, Ranjan A, Mathkor DM, Haque S, Ramniwas S, Tuli HS, Jindal T, Yadav V. Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability. Front Microbiol. 2024 Apr 29;15:1403168. DOI: https://doi.org/10.3389/fmicb.2024.1403168
23. Tong C, Hu H, Chen G et al. Disinfectant resistance in bacteria: Mechanisms, spread, and resolution strategies. Environmental Research. 2021, 110897. DOI: https://doi.org/10.1016/j.envres.2021.110897
24. Ahmed SK, Hussein S, Qurbani K et al. Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health. 2024, 100081. DOI: https://doi.org/10.1016/j.glmedi.2024.100081
25. Verdial C, Serrano I, Tavares L, Gil S, Oliveira M. Mechanisms of Antibiotic and Biocide Resistance That Contribute to Pseudomonas aeruginosa Persistence in the Hospital Environment. Biomedicines. 2023; 11(4):1221. DOI: https://doi.org/10.3390/biomedicines11041221
26. Zack KM, Sorenson T, Joshi SG. Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii. Pathogens. 2024; 13(3):197. DOI: https://doi.org/10.3390/pathogens13030197
27. Ponzo E, De Gaetano S, Midiri A, Mancuso G, Giovanna P, Giuliana D, Zummo S, Biondo C. The Antimicrobial Resistance Pandemic Is Here: Implementation Challenges and the Need for the One Health Approach. Hygiene. 2024; 4(3):297-316. DOI: https://doi.org/10.3390/hygiene4030024
28. Maillard JY, Bloomfield SF, Courvalin P, Essack SY, Gandra S, Gerba CP, Rubino JR, Scott EA. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper. Am J Infect Control. 2020 Sep;48(9):1090-1099. DOI: https://doi.org/10.1016/j.ajic.2020.04.011
29. Chiș AA, Rus LL, Morgovan C, Arseniu AM, Frum A, Vonica-Țincu AL, Gligor FG, Mureșan ML, Dobrea CM. Microbial Resistance to Antibiotics and Effective Antibiotherapy. Biomedicines. 2022 May 12;10(5):1121. DOI: https://doi.org/10.3390/biomedicines10051121
30. Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics (Basel). 2020 Dec 23;10(1):3. DOI: https://doi.org/10.3390/antibiotics10010003
31. Weisberg AJ, Chang JH. Mobile Genetic Element Flexibility as an Underlying Principle to Bacterial Evolution. Annu Rev Microbiol. 2023 Sep 15;77:603-624. DOI: https://doi.org/10.1146/annurev-micro-032521-022006
32. van Duin D, Paterson DL. Multidrug-Resistant Bacteria in the Community: An Update. Infect Dis Clin North Am. 2020 Dec;34(4):709-722. DOI: https://doi.org/10.1016/j.idc.2020.08.002
33. Algammal AM, Hetta HF, Elkelish A, Alkhalifah DHH, Hozzein WN, Batiha GE, El Nahhas N, Mabrok MA. Methicillin-Resistant Staphylococcus aureus (MRSA): One Health Perspective Approach to the Bacterium Epidemiology, Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact. Infect Drug Resist. 2020 Sep 22;13:3255-3265. DOI: https://doi.org/10.2147/IDR.S272733
34. Baroud M, Dandache I, Araj GF, Wakim R, Kanj S, Kanafani Z, Khairallah M, Sabra A, Shehab M, Dbaibo G, Matar GM. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents. 2013 Jan;41(1):75-9. DOI: https://doi.org/10.1016/j.ijantimicag.2012.08.010
35. Mishra R, Shukla P, Huang W, Hu N. Gene mutations in Mycobacterium tuberculosis: multidrug-resistant TB as an emerging global public health crisis. Tuberculosis (Edinb). 2015 Jan;95(1):1-5. DOI: https://doi.org/10.1016/j.tube.2014.08.012
36. Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021 Mar 19;10(3):373. DOI: https://doi.org/10.3390/pathogens10030373
37. Espinosa K, Park JA, Gerrity JJ, Buono S, Shearer A, Dick C, Mak ML, Teramoto K, Klausner JD, Pandori M, Hess D. Fluoroquinolone resistance in Neisseria gonorrhoeae after cessation of ciprofloxacin usage in San Francisco: using molecular typing to investigate strain turnover. Sex Transm Dis. 2015 Feb;42(2):57-63. DOI: https://doi.org/10.1097/OLQ.0000000000000233
38. Kumar S, Kumar A, Roudbary M, Mohammadi R, Černáková L, Rodrigues CF. Overview on the Infections Related to Rare Candida Species. Pathogens. 2022 Aug 24;11(9):963. DOI: https://doi.org/10.3390/pathogens11090963
39. McEwen SA, Collignon PJ. Antimicrobial Resistance: a One Health Perspective. Microbiol Spectr. 2018 Mar;6(2):10.1128/microbiolspec.arba-0009-2017. DOI: https://doi.org/10.1128/microbiolspec.ARBA-0009-2017
40. Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. Molecules. 2018 Mar 30;23(4):795. DOI: https://doi.org/10.3390/molecules23040795
41. Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare (Basel). 2023 Jul 5;11(13):1946. DOI: https://doi.org/10.3390/healthcare11131946
42. Du Plessis GM. Microbial Geopolitics: Living with Danger and the Future of Security. PhD diss (2017).
43. Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med. 2019 Dec 23;26(8):taz036. DOI: https://doi.org/10.1093/jtm/taz036
44. Oliveira M, Antunes W, Mota S, Madureira-Carvalho Á, Dinis-Oliveira RJ, Dias da Silva D. An Overview of the Recent Advances in Antimicrobial Resistance. Microorganisms. 2024; 12(9):1920. DOI: https://doi.org/10.3390/microorganisms12091920
45. WHO. Antimicrobial resistance. Available at https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance#:~:text=AMR%20puts%20many%20of%20the,novel%20vaccines%2C%20diagnostics%20and%20medicines (Accessed 10 January 2026).
46. An Overview of our Hygiene and Textile Standards. Available at: https://microbiome-friendly.com/en/textile-standards#:~:text=An%20Overview%20of%20our%20Hygiene,even%20the%20most%20delicate%20skin.
47. Huttner B, Saam M, Moja L, Mah K, Sprenger M, Harbarth S, Magrini N. How to improve antibiotic awareness campaigns: findings of a WHO global survey. BMJ Glob Health. 2019 May 9;4(3):e001239. DOI: https://doi.org/10.1136/bmjgh-2018-001239
48. Lompo P, Heroes A-S, Agbobli E, Kühne V, Tinto H, Affolabi D, Jacobs J. Bacterial Contamination of Antiseptics, Disinfectants and Hand Hygiene Products in Healthcare Facilities in High-Income Countries: A Scoping Review. Hygiene. 2023; 3(2):136-175. DOI: https://doi.org/10.3390/hygiene3020012
49. Ahmed R, Hoque M, Hasan MN. Scabies Prevalence and Management in Bangladesh: A Narrative Review. Bangladesh J Infect Dis 2025;12(1):151-158. DOI: https://doi.org/10.3329/bjid.v12i1.83987
50. World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2023. Geneva: WHO; 2023.
51. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022 Feb 12;399(10325):629-655. DOI: https://doi.org/10.1016/S0140-6736(21)02724-0
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
